Publications

Sirois AR, Deny DA, Li Y, Fall YD, Moore SJ. (2020) Engineered Fn3 protein has targeted therapeutic effect on mesothelin-expressing cancer cells and increases tumor cell sensitivity to chemotherapy. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.27204

Kim JS, Sirois AR, Vazquez Cegla AJ, Jumai’an E, Murata N, Buck ME, Moore SJ. (2019) Protein-polymer conjugates synthesized using water-soluble azlactone-functionalized polymers enable receptor-specific cellular uptake towards targeted drug delivery. Bioconjugate Chemistry 30(4): 1220-1231. https://pubs.acs.org/doi/10.1021/acs.bioconjchem.9b00155

Sirois AR, Deny DA, Baierl SR, George KS, Moore SJ. (2018) Fn3 proteins engineered to recognize tumor biomarker mesothelin internalize upon binding. PLoS ONE 13(5): e0197029. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0197029

S.J. Moore, M.G. Hayden Gephart, J.M. Bergen, Y.S. Su, H. Rayburn, M.P. Scott, J.R. Cochran. “Engineered knottin peptide enables non-invasive optical imaging of intracranial medulloblastoma.” Proc. Natl. Acad. Sci. USA, 2013. 110(36): 14598-14603.

S.J. Moore, C.L. Leung, H.K. Norton, and J.R. Cochran. “Engineering Agatoxin, a cystine-knot peptide from spider venom, as a molecular probe for in vivo tumor imaging.” PLOS ONE, 2013. 8: e60498.

H. Jiang, S.J. Moore, S. Liu, H. Liu, Z. Miao, F.V. Cochran, Y. Liu, M. Tian, J.R. Cochran, H. Zhang, and Z. Cheng. “A novel radiofluorinated agouti-related protein for tumor angiogenesis imaging.” Amino Acids, 2013. DOI: 10.1007/s00726-012-1391-y.

S.J. Moore and J.R. Cochran. “Engineering Knottins as Novel Binding Agents.”Methods in Enzymology, 2012. 503: 223-251.

S.J. Moore, C.L. Leung, and J.R. Cochran. “Knottins: Disulfide-bonded Therapeutic and Diagnostic Peptides.” Drug Discovery Today: Technologies, 2012. 9: e3-e11.